{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:03:04Z","timestamp":1780531384915,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpba.2026.117559","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:36:41Z","timestamp":1778812601000},"page":"117559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Investigation of the on-column oxidative formation of impurity D during amlodipine impurities profiling by UHPLC"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-6585","authenticated-orcid":false,"given":"Michal","family":"Dou\u0161a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Kal\u00e1\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117559_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0021-9673(99)01135-8","article-title":"Investigations of artifact peaks in sensitive high-performance liquid chromatography methods","volume":"869","author":"Strasser","year":"2000","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2026.117559_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chroma.2004.07.110","article-title":"Ghost peaks in reversed-phase gradient HPLC: a review and update","volume":"1052","author":"Williams","year":"2004","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2026.117559_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpba.2016.10.004","article-title":"The importance of vial composition in HPLC analysis: an unusual case of phosphorous pseudorotation","volume":"134","author":"Arvary","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117559_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpba.2017.02.059","article-title":"Ghost peaks\u201d of ezetimibe: solution degradation products of ezetimibe in acetonitrile induced by alkaline impurities from glass HPLC vials","volume":"140","author":"Jin","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117559_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpba.2017.11.052","article-title":"Ghost peak\u201d of clofazimine: a solution degradation product of clofazimine via nucleophilic substitution by nitrite leaching from certain glass HPLC vials","volume":"150","author":"Lin","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117559_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpba.2016.03.040","article-title":"Formation of copper(I) from trace levels of copper(II) as an artifactual impurity in the HPLC analysis of olanzapine","volume":"125","author":"Baertschi","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117559_bib7","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/j.chroma.2011.04.004","article-title":"Chromatographic studies of unusual on-column degradations of aniline compounds on XBridge Shield RP18 column in high pH aqueous mobile phase","volume":"1218","author":"Wang","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2026.117559_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.chroma.2013.10.021","article-title":"On-column nitrosation of amines observed in liquid chromatography impurity separations employing ammonium hydroxide and acetonitrile as mobile phase","volume":"1319","author":"Myers","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2026.117559_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112818","article-title":"Chromatographic studies of unusual on-column degradation of cefaclor observed in the impurity separation by HPLC","volume":"176","author":"Zhong","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117559_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0021-9673(00)89250-X","article-title":"Chromatography of metal chelates: VII. High-performance liquid chromatography of metal 1,2-diketobisthiobenzhydrazones, metal dialkyldithiocarbamates and metal 1,2-diketobisthiosemicarbazones","volume":"137","author":"Heizmann","year":"1977","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2026.117559_bib11","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/rcm.7291","article-title":"Observation and confirmation of oxidation reactions occurring on ultra-high-performance liquid chromatography columns","volume":"29","author":"Tang","year":"2015","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2026.117559_bib12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2165\/00003495-199141030-00009","article-title":"Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease","volume":"41","author":"Murdoch","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2026.117559_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpba.2018.07.040","article-title":"Identification and structure elucidation of a new degradation impurity in the multi-component tablets of amlodipine besylate","volume":"162","author":"Gibala","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117559_bib14","unstructured":"T. Aslan, M. Adiyaman, A. Yurdakul, F. Sahpaz, E.A. Ozarslan, D. Guner, N. Ridvanoglu, Isolation of dihydropyridine derivative and preparation salts thereof, WO 2004\/058711 A1."},{"key":"10.1016\/j.jpba.2026.117559_bib15","unstructured":"European Pharmacopoeia (Ph. Eur.) Amlodipine besylate monograph 01\/2026:1491, 9th Edition."},{"key":"10.1016\/j.jpba.2026.117559_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jpba.2005.10.029","article-title":"Identification and characterization of potential impurities of amlodipine maleate","volume":"40","author":"Sudhakar","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117559_bib17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/rcm.2490","article-title":"A qualitative study of amlodipine and its related compounds by electrospray ionization tandem mass spectrometry","author":"Gibbons","year":"2006","journal-title":"Rapid. Commun. Mass. Spectrom. 20"},{"key":"10.1016\/j.jpba.2026.117559_bib18","first-page":"443","article-title":"Separation, identification and structural elucidation of a new impurity in the drug substance of smlodipine maleate using LC-MS\/MS NMR and IR","volume":"83","author":"Reddy","year":"2010","journal-title":"Croat. Chem. Acta"},{"key":"10.1016\/j.jpba.2026.117559_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2298\/CICEQ121226011S","article-title":"Investigation of forced and total degradation products of amlodipine besylate by liquid chromatography and liquid chromatography-mass spectrometry","volume":"20","author":"Stoiljkovi\u0107","year":"2014","journal-title":"Chem. Ind. Chem. Eng. Q."},{"key":"10.1016\/j.jpba.2026.117559_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-397220-0.00002-7","article-title":"Amlodipine Besylate","volume":"37","author":"Ananchenko","year":"2012","journal-title":"Profiles Drug Subst. Excip. Relat. Method."},{"key":"10.1016\/j.jpba.2026.117559_bib21","unstructured":"Amlodipine Besilate, European Pharmacopoeia 11.3, 04\/2016:1491."},{"key":"10.1016\/j.jpba.2026.117559_bib22","first-page":"74","article-title":"Peak purity in liquid chromatography, Part 1: basic concepts, commercial software, and limitations","volume":"31","author":"Stoll","year":"2018","journal-title":"LCGC Eur."},{"key":"10.1016\/j.jpba.2026.117559_bib23","first-page":"768","article-title":"Detecting coeluted impurities by spectral comparison","volume":"12","author":"Gorenstein","year":"1994","journal-title":"LCGC"},{"key":"10.1016\/j.jpba.2026.117559_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/chromsci\/44.8.523","article-title":"Subcritical solvent regeneration of contaminated HPLC columns used for separating biomolecules","volume":"44","author":"Zhang","year":"2006","journal-title":"J. Chrom. Sci."},{"key":"10.1016\/j.jpba.2026.117559_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/cr00048a004","article-title":"Recent advances in the chemistry of dihydropyridines","volume":"82","author":"Stout","year":"1982","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jpba.2026.117559_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/ja00367a026","article-title":"The pyridinium\u2013dihydropyridine system: reduction potentials and the mechanism of oxidation of 1,4-dihydropyridines","volume":"104","author":"Srinivasan","year":"1982","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jpba.2026.117559_bib27","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/hlca.19840670834","article-title":"Clay-supported reagent-aromatization of 1, 4-dihydropyridines by clay-supported metal nitrate","volume":"67","author":"Balogh","year":"1984","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.jpba.2026.117559_bib28","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1081\/SCC-120018693","article-title":"An efficient Co(II) catalyzed auto oxidation of 1, 4-dihydropyridines","volume":"33","author":"Chavan","year":"2003","journal-title":"Synth. Commun."},{"key":"10.1016\/j.jpba.2026.117559_bib29","first-page":"603","article-title":"A new method for the oxidation of 1, 4-dihydropyridine derivatives by guanidinium nitrate in the presence of silica sulfuric acid under mild, heterogeneous and metal-free conditions","volume":"20","author":"Nikoorazm","year":"2013","journal-title":"Sci. Iran."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852600227X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852600227X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:22:52Z","timestamp":1780528972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852600227X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"alternative-id":["S073170852600227X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117559","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the on-column oxidative formation of impurity D during amlodipine impurities profiling by UHPLC","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117559"}}